References
- Adjemian J, Hartnett KP, Kite-Powell A, DeVies J, Azondekon R, Radhakrishnan L, van Santen KL, Rodgers L. Update: COVID-19 Pandemic-Associated Changes in Emergency Department Visits - United States, December 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021;70(15):552–6. doi:https://doi.org/10.15585/mmwr.mm7015a3.
- Mendell G. Addressing the addiction crisis during a pandemic. Am J Health Promot. 2021;35(2):317–9. doi:https://doi.org/10.1177/0890117120983982.
- Strathdee SA. A glass half empty or a glass half full? Addressing the opioid crisis through the lens of COVID-19. Drug Alcohol Depend. 2021;222:108680. doi:https://doi.org/10.1016/j.drugalcdep.2021.108680.
- Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 Pandemic on Service Access for People who Use Drugs (PWUD): A national qualitative study. J Subst Abuse Treat. 2021;129:108374. doi:https://doi.org/10.1016/j.jsat.2021.108374.
- Doraiswamy S, Abraham A, Mamtani R, Cheema S. Use of telehealth during the COVID-19 pandemic: Scoping review. J Med Internet Res. 2020;22(12):e24087. doi:https://doi.org/10.2196/24087.
- IBM Corp. Released 2020. IBM SPSS Statistics, Version 27.0. Armonk, NY: IBM Corp.
- Mellis AM, Potenza MN, Hulsey JN. COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns. J Subst Abuse Treat. 2021;121:108180. doi:https://doi.org/10.1016/j.jsat.2020.108180.
- Ornell F, Moura HF, Scherer JN, Pechansky F, Kessler F, von Diemen L. The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. Psychiatry Res. 2020;289:113096. Advance online publication. doi:https://doi.org/10.1016/j.psychres.2020.113096.